Yi Xu

12PUBLICATIONS
30CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 21, 2026
TTLL12 counteracts BPOZ-2 to stabilize eEF1A1 and promote hepatocarcinogenesis.

|Aug 18, 2025
Clathrin Light Chain B Drives Hepatocellular Carcinoma Progression Through Dual Mechanisms: Small Extracellular Vesicle-Mediated Angiogenesis and the NF-κB-PCLAF Signaling Axis.

Xiaoke Sun, Junchen Guo, Ning Zhao

|Apr 10, 2025
Unraveling the Role of the Wnt Pathway in Hepatocellular Carcinoma: From Molecular Mechanisms to Therapeutic Implications.

Zixin Liang, Shanshan Li, Zhiyu Wang

|Feb 07, 2025
Exosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression.

Yifei Ge, Lixue Jiang, Qingfu Dong

|Aug 22, 2023
Clathrin light chain A-enriched small extracellular vesicles remodel microvascular niche to induce hepatocellular carcinoma metastasis.

Yi Xu, Yue Yao, Liang Yu

|Aug 14, 2023
Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review.

Xudong Zhao, Yudan Wang, Haoming Xia

Pageof 2

Frequent Collaborators

6 joint publications

Judy Wai Ping Yam

3 joint publications

Wangyang Zheng

3 joint publications

Yunfu Cui

2 joint publications

Peng Huang